() Loxicom® Oral suspension | Norbrook Laboratories


(meloxicam oral suspension) 1.5 mg/mL   


A non-steroidal anti-inflammatory drug (NSAID) for the control of pain and inflammation associated with osteoarthritis (OA) in dogs. Contains the same active ingredient and is bioequivalent to Metacam® (meloxicam oral suspension) 1.5 mg/mL.

Target Species: Dogs

Product Attributes

  • Nearly 100% bioavailability when administered orally with food, meaning all of the active ingredient will be available to have an effect

  • Less expensive than Metacam® (meloxicam oral suspension) 1.5 mg/mL, offering significant savings and improved clinic profit potential

  • No tablet splitting for accurate dosing

  • May be mixed with food or dosed directly into the mouth

  • Odorless for easier administration

  • Convenient 2 x 100 mL sizing ideal for treating large breed dogs for OA

  • Packaged in clear bottles to easily view remaining contents

  • Calibrated syringes for simple, precise dosing based on a dog’s weight

  • Available in convenient 10 mL, 32 mL, 100 mL and 2 x 100 mL bottles with 1.5 mg/mL strength

Observe label directions. Do not use Loxicom® Oral Suspension in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. As with any medication, side effects may occur. These are usually mild, but may be serious. The most common side effects reported in field studies were vomiting, soft stool/diarrhea and decreased appetite. If side effects occur, discontinue treatment immediately and consult a veterinarian. Dogs should be evaluated for pre-existing medical conditions prior to treatment and monitored during therapy. See product labeling for full product, safety, and adverse event reporting information.

  • Active Ingredient(s)


  • Dosage Form and Description

    Oral suspension: pale yellow 

  • Indications

    Loxicom® Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs

  • Dosage and Administration

    Loxicom® Oral Suspension should be administered initially at 0.09 mg/lb (0.2 mg/kg) body weight only on the first day of treatment. For all treatments after day 1, Loxicom® Oral Suspension should be administered once daily at a dose of 0.045 mg/lb (0.1 mg/ kg). The syringes are calibrated to deliver the daily maintenance dose in lbs. Because the first dose (0.2 mg/kg) is two times the amount of the daily maintenance dose (0.1 mg/kg), two syringes containing the 0.1 mg/kg dose should be administered at the first dose.

    Loxicom Oral Suspension Dosing Chart

  • Storage

    Store at controlled room temperature 68°-77°F (20°-25°C). Excursions permitted between 59°F and 86°F (15°C and 30°C). Brief exposure to temperature up to 104°F (40°C) may be tolerated provided the mean kinetic temperature does not exceed 77°F (25°C); however such exposure should be minimized.

© 2023 Norbrook Laboratories Limited. The Norbrook logo and Loxicom are registered trademarks of Norbrook Laboratories Limited. Metacam is a registered trademark of Boehringer Ingelheim Vetmedica, Inc.

If you are a pet owner looking to purchase Loxicom® Oral Suspension, please consult with your local veterinarian.

Prefer to speak directly to a member of our team?

Norbrook®, Inc.

We are open Mon - Fri 8:00am - 5:00pm CST

Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.